Disclosure Of Interests In Other Entities [Text Block]

Tchaikapharma High Quality Medicines AD - Filing #6023728

Concept	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	As at 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	As at 2021-12-31
Disclosure of interests in other entities [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of interests in subsidiaries [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of subsidiaries [text block]	—	—	SS	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of subsidiaries [abstract]
Disclosure of subsidiaries [line items]
Profit (loss), attributable to non-controlling interests	—	—	- BGN	—	—	—	—	—	—	—	—	- BGN	—	—	—	—	—
Non-controlling interests	—	—	—	—	- BGN	—	—	—	- BGN	—	—	—	—	—	—	—	—
Current assets	—	—	—	—	80 878 BGN	—	—	—	75 705 BGN	—	—	—	—	—	—	—	—
Non-current assets	—	—	—	—	41 621 BGN	—	—	—	44 156 BGN	—	—	—	—	—	—	—	—
Current liabilities	—	—	—	—	15 309 BGN	—	—	—	15 644 BGN	—	—	—	—	—	—	—	—
Non-current liabilities	—	—	—	—	2 189 BGN	—	—	—	2 632 BGN	—	—	—	—	—	—	—	—
Revenue	—	—	48 512 BGN	—	—	—	—	—	—	—	—	43 146 BGN	—	—	—	—	—
Profit (loss)	- BGN	- BGN	3 398 BGN	- BGN	—	- BGN	3 398 BGN	3 398 BGN	—	- BGN	- BGN	2 790 BGN	- BGN	2 790 BGN	2 790 BGN	- BGN	—
Comprehensive income	- BGN	- BGN	3 416 BGN	18,000 BGN	—	- BGN	3 398 BGN	3 416 BGN	—	- BGN	- BGN	2 766 BGN	24,000 BGN	2 766 BGN	2 790 BGN	- BGN	—
Disclosure of interests in associates [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of associates [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of associates [abstract]
Disclosure of associates [line items]
Other comprehensive income	- BGN	- BGN	18,000 BGN	18,000 BGN	—	- BGN	- BGN	18,000 BGN	—	- BGN	- BGN	24,000 BGN	24,000 BGN	24,000 BGN	- BGN	- BGN	—
Disclosure of interests in joint arrangements [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of joint ventures [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of joint ventures [abstract]
Disclosure of joint ventures [line items]
Cash and cash equivalents	—	—	—	—	73,000 BGN	—	—	—	142,000 BGN	—	—	—	—	—	—	—	57,000 BGN
Depreciation and amortisation expense	—	—	2 809 BGN	—	—	—	—	—	—	—	—	3 568 BGN	—	—	—	—	—
Tax expense (income)	—	—	470,000 BGN	—	—	—	—	—	—	—	—	342,000 BGN	—	—	—	—	—